Bioscience

Cerapedics appoints Doug Kohrs to board and names Antony Koblish chair

Cerapedics appoints Doug Kohrs to board and names Antony Koblish chair

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, announced the appointment of Doug Kohrs to the company's board of directors and the appointment of Antony Koblish as board... Read More

Wednesday October 25, 2017 0 comments Tags: Westminster, Cerapedics, Doug Kohrs, Antony Koblish, Glen Kashuba

High Tech Health International awarded patent for lowest total EMF infrared sauna heater

High Tech Health International awarded patent for lowest total EMF infrared sauna heater

BOULDER -- High Tech Health International, Inc. , a leading supplier of infrared saunas for health, announced the award of a patent for its invention of the first infrared sauna heater that is... Read More

Tuesday October 24, 2017 0 comments Tags: Denver, High Tech Health, Erik Johnson

Mary’s Nutritionals offers two new supplements

Mary’s Nutritionals offers two new supplements

DENVER -- Mary's Nutritionals announced its newest cannabinoid innovation: two variations of organic, hemp-infused supplements that utilize the powerful combination of activated hemp extract,... Read More

Thursday October 19, 2017 0 comments Tags: Denver, Mary's Nutritionals, Mary's Medicinals, Lynn Honderd, Jeremy Riggle

UNC partners with PharmaCyte Biotech in cannabis drug research

UNC partners with PharmaCyte Biotech in cannabis drug research

GREELEY/LAGUNA HILLS, Calif. -- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its... Read More

Wednesday October 18, 2017 0 comments Tags: Greeley, UNC, PharmaCyte, cannabis research, Cell-in-a-Box

Aytu BioScience announces stock uplisting to NASDAQ Capital Market on Oct. 20

Aytu BioScience announces stock uplisting to NASDAQ Capital Market on Oct. 20

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced its shares of... Read More

Wednesday October 18, 2017 0 comments Tags: Englewood, Aytu BioScience, Josh Disbrow

Ampio seeks to raise $6.75M through stock sale

Ampio seeks to raise $6.75M through stock sale

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced it has entered into a securities purchase agreement with investors for the registered sale of approximately$6.75... Read More

Tuesday October 17, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals

Clovis Oncology submits NDA for rucaparib to treat recurrent ovarian cancer

Clovis Oncology submits NDA for rucaparib to treat recurrent ovarian cancer

BOULDER -- Clovis Oncology (NASDAQ: CLVS) today announced it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for rucaparib as maintenance... Read More

Tuesday October 10, 2017 0 comments Tags: Boulder, Clovis Oncology, Rucaparib, Patrick J. Mahaffey, FDA

CU Boulder study: Light-activated nanoparticles can supercharge antibiotics

CU Boulder study: Light-activated nanoparticles can supercharge antibiotics

BOULDER -- Light-activated nanoparticles, also known as quantum dots, can provide a crucial boost in effectiveness for antibiotic treatments used to combat drug-resistant superbugs such as E .... Read More

Thursday October 5, 2017 0 comments Tags: Boulder, CU Boulder, Prashant Nagpal, Anushree Chatterjee